CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation

Circ Res. 2010 Apr 2;106(6):1134-44. doi: 10.1161/CIRCRESAHA.109.203836. Epub 2010 Jan 7.

Abstract

Rationale: Although research suggests that diastolic Ca(2+) levels might be increased in atrial fibrillation (AF), this hypothesis has never been tested. Diastolic Ca(2+) leak from the sarcoplasmic reticulum (SR) might increase diastolic Ca(2+) levels and play a role in triggering or maintaining AF by transient inward currents through Na(+)/Ca(2+) exchange. In ventricular myocardium, ryanodine receptor type 2 (RyR2) phosphorylation by Ca(2+)/calmodulin-dependent protein kinase (CaMK)II is emerging as an important mechanism for SR Ca(2+) leak.

Objective: We tested the hypothesis that CaMKII-dependent diastolic SR Ca(2+) leak and elevated diastolic Ca(2+) levels occurs in atrial myocardium of patients with AF.

Methods and results: We used isolated human right atrial myocytes from patients with AF versus sinus rhythm and found CaMKII expression to be increased by 40+/-14% (P<0.05), as well as CaMKII phosphorylation by 33+/-12% (P<0.05). This was accompanied by a significantly increased RyR2 phosphorylation at the CaMKII site (Ser2814) by 110+/-53%. Furthermore, cytosolic Ca(2+) levels were elevated during diastole (229+/-20 versus 164+/-8 nmol/L, P<0.05). Most likely, this resulted from an increased SR Ca(2+) leak in AF (P<0.05), which was not attributable to higher SR Ca(2+) load. Tetracaine experiments confirmed that SR Ca(2+) leak through RyR2 leads to the elevated diastolic Ca(2+) level. CaMKII inhibition normalized SR Ca(2+) leak and cytosolic Ca(2+) levels without changes in L-type Ca(2+) current.

Conclusion: Increased CaMKII-dependent phosphorylation of RyR2 leads to increased SR Ca(2+) leak in human AF, causing elevated cytosolic Ca(2+) levels, thereby providing a potential arrhythmogenic substrate that could trigger or maintain AF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Anesthetics, Local / pharmacology
  • Atrial Fibrillation / enzymology*
  • Atrial Fibrillation / pathology
  • Atrial Fibrillation / physiopathology
  • Benzylamines / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling* / drug effects
  • Calcium-Binding Proteins / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Case-Control Studies
  • Cell Size
  • Diastole
  • Heart Atria / enzymology
  • Humans
  • Microscopy, Confocal
  • Myocardium / enzymology*
  • Myocardium / pathology
  • Patch-Clamp Techniques
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / enzymology*
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Sodium-Calcium Exchanger / metabolism
  • Sulfonamides / pharmacology
  • Systole
  • Tetracaine / pharmacology
  • Time Factors
  • Up-Regulation

Substances

  • Anesthetics, Local
  • Benzylamines
  • Calcium Channels, L-Type
  • Calcium-Binding Proteins
  • Protein Kinase Inhibitors
  • Ryanodine Receptor Calcium Release Channel
  • Sodium-Calcium Exchanger
  • Sulfonamides
  • phospholamban
  • Tetracaine
  • KN 93
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • ATP2A2 protein, human